Skip to main content
Watch Insiders
CDTHealthcare

Conduit Pharmaceuticals Inc (CDT) Insider Trading

In the last 90 days, 1 Conduit Pharmaceuticals Inc (CDT) insider reported no open-market purchases and 1 sale totaling $0.00. Source: SEC Form 4 filings.

SEC-reported filing activity is provided for research purposes and is not investment advice.

90-day C-suite buyers
0
90-day purchase value
$0.00
Corporate buyers
0
Latest transaction
Aug 28, 2026

Executive filings

Open-market transaction history

Purchase and sale summaries are ordered by the latest reported transaction date.

Open-market insider purchase and sale transactions
DateInsider nameRoleTypeSharesPriceTotal value
Aug 28, 2026Andrew ReganChief Executive OfficerSale290$0.00$0.00
Jun 18, 2026Mark Andrew TaylorCorporate insiderSale2,068,000$1.42$2,945,659
Jun 18, 2026Prospect Capital Securities LtdCorporate insiderSale2,068,000$1.42$2,945,659
Jun 18, 2026Prospect Finance LtdCorporate insiderSale2,068,000$1.42$2,945,659

Common questions

CDT insider trading FAQ

Are CDT insiders buying or selling?
Over the last 90 days, CDT insiders were net buyers, reporting $0.00 of open-market purchases and $0.00 of sales.
When was the last CDT insider purchase?
No open-market insider purchase of Conduit Pharmaceuticals Inc stock was reported in the last 90 days.
Where does CDT insider trading data come from?
Watch Insiders reads the SEC Form 4 filings that Conduit Pharmaceuticals Inc officers, directors, and 10% owners submit to EDGAR, and refreshes this page daily.